热门资讯> 正文
Novartis inks $1.7 billion drug target agreement with UK’s Relation Therapeutics
2025-12-09 14:36
- 诺华(NVS) 0
- 研控科技(RCON) 0
- 正康国际(ZKIN) 0
Novartis AG (NVS) to pay UK biotech Relation Therapeutics Ltd. as much as $1.7 billion to help find drug targets to treat allergic diseases.
The deal aims to combine Novartis’s (NVS) expertise in immuno-dermatology with the British firm’s drug discovery AI platform, which uses patient data, including from human tissue, to unpack the genetic basis for how diseases present, Relation’s CEO David Roblin told Bloomberg News in an interview.
More on Novartis
- Novartis AG (NVS) Discusses Social Impact, Global Health Initiatives, and Sustainability Strategy Transcript
- Novartis AG (NVS) Discusses Social Impact, Global Health Initiatives, and Sustainability Strategy - Slideshow
- Novartis AG (NVS) Shareholder/Analyst Call Transcript
- Notable analyst calls this week: Novartis, Albemarle and Zscaler among top picks
- Novartis upgraded at Morgan Stanley on stock pullback, Rhapsido launch
推荐文章
美股机会日报 | 就业数据转弱！美国至2月7日当周初请失业金人数超预期；存储概念股盘前齐升，闪迪大涨超7%
要点速递！《跑赢美股》春节特别直播核心观点总结
华盛早报 | 非农数据大超预期！首次降息或延至7月；AI恐慌交易蔓延至房地产服务板块， CBRE暴跌12%；智谱发布新模型
美股机会日报 | 经济数据强劲！美国1月非农就业大超预期，纳指期货涨至0.6%；AI应用股业绩超预期，Shopify涨超10%
资金复盘 | 北水净买入港股超48亿港元，逾7亿港元抢筹腾讯
华盛早报 | “AI威胁”波及华尔街！财富管理公司全线暴跌；豆包官宣“参战”！春节AI红包战愈演愈烈
美股机会日报 | 科技巨头迎利好？特朗普政府拟结构性豁免芯片关税；台积电1月销售额创历史新高，盘前股价涨近3%
一图看懂 | 净利大增60.7%！中芯国际Q4营收24.9亿美元，同比增长12.8%
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
